Form 4 for GILD Gilead Sciences
Accepted 2023-11-13 00:00:00 ET · period of report 2023-11-10 · accession 0001127602-23-027287 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-13 | 2023-11-10 | GILD | Dickinson Andrew D | CFO | M - OptEx | — | +1,912 | 105.9K | +2% | — |
| D | 2023-11-13 | 2023-11-10 | GILD | Dickinson Andrew D | CFO | F - Tax | $75.92 | -804 | 105.1K | -0.8% | -$61.0K |
| D | 2023-11-13 | 2023-11-10 | GILD | Dickinson Andrew D | CFO | M - OptEx | — | -1,912 | 41.5K | -4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-10 | M | A | 1,912 | — | 105,915 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2023-11-10 | F | D | 804 | $75.92 | 105,111 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-11-10 | M | D | 1,912 | — | 41,451 | D | — · — to — | 1,912 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. |